Margeaux King
Psychiatric/Mental Health · Denver, CONPI 1891334454
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 199 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 199 payments — averaging $23.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$854
- Axsome Therapeutics, Inc.$556
- Alkermes, Inc.$526
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$336
- Corium, LLC$292
- Supernus Pharmaceuticals, Inc.$230
- plus $2K from 22 others
What the payments were for
- Food & beverage$4,608100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 40 | $854 |
| Axsome Therapeutics, Inc. | 15 | $556 |
| Alkermes, Inc. | 20 | $526 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 15 | $336 |
| Corium, LLC | 13 | $292 |
| Supernus Pharmaceuticals, Inc. | 11 | $230 |
| Otsuka America Pharmaceutical, Inc. | 9 | $182 |
| Johnson & Johnson | 7 | $147 |
| Eisai Inc. | 6 | $138 |
| Sunovion Pharmaceuticals Inc. | 10 | $130 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $124 |
| Bausch Health US, LLC | 6 | $121 |
| Neurocrine Biosciences, Inc. | 6 | $120 |
| Teva Pharmaceuticals USA, Inc. | 5 | $116 |
| Boehringer Ingelheim | 1 | $113 |
| Tris Pharma Inc | 3 | $112 |
| Ironshore Pharmaceuticals Inc. | 5 | $94 |
| Lundbeck LLC | 4 | $75 |
| Collegium Pharmaceutical, Inc. | 3 | $59 |
| Idorsia Pharmaceuticals US Inc | 3 | $53 |
| Brainsway USA Inc | 1 | $45 |
| Novo Nordisk | 2 | $37 |
| Avanir Pharmaceuticals, Inc. | 2 | $35 |
| Vertical Pharmaceuticals, LLC | 2 | $35 |
| Vanda Pharmaceuticals Inc. | 1 | $30 |
| Noven Therapeutics, LLC | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Tempus AI, Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,608 in reported general payments places this provider in the 90th percentile of 873 psychiatric/mental health providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 16 | $388 |
| Duloxetine Hcl | 24 | $317 |
| Lamotrigine | 11 | $251 |
| Mirtazapine | 11 | $240 |
| Bupropion XlBupropion Hcl | 12 | $202 |
| Quetiapine Fumarate | 15 | $157 |
| Fluoxetine Hcl | 20 | $138 |
| Alprazolam | 23 | $134 |
| Eszopiclone | 12 | $101 |
| Gabapentin | 15 | $67 |
| Trazodone Hcl | 11 | $56 |
| Lorazepam | 18 | $46 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Denver
- Audrey StrockDenver$499K
- Deborah YorkDenver$158K
- Ivy HooDenver$8K
- Mary EvansDenver$7K
- Kristina MordecaiDenver$6K
- Brandon BurelleDenver$5K
- Nataliya HayesDenver$4K
- Laira CowperDenver$4K
- Mykol WarnerDenver$4K
- Chelsie MonroeLittleton$998K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.